CUTERA INC
CUTRHealthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $54.5M | $58.0M | $231.3M | $147.7M | $181.7M | $162.7M |
| Operating income | −$156.2M | −$38.2M | $1.8M | −$22.8M | −$12.1M | −$13.4M |
| Net income | −$28.0M | −$15.1M | $2.1M | −$23.9M | −$12.3M | −$30.8M |
| Total assets | $346.3M | $521.0M | $280.3M | $132.7M | $113.7M | $97.6M |
| Total liabilities | $518.1M | $536.2M | $223.7M | $75.9M | $67.8M | $51.3M |
| Equity | −$171.8M | −$15.2M | $56.6M | $56.9M | $45.9M | $46.4M |
| EPS (diluted) | $-1.42 | $-0.84 | $0.11 | $-1.43 | $-0.88 | $-0.15 |
| Shares out. | 19.8M | 18.1M | 17.8M | 14.4M | 14.0M | 13.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −286.5%
- Net margin
- −51.4%
- Return on equity
- 16.3%
- Return on assets
- −8.1%
- Return on capital (ROCE)
- −65.7%
- Liabilities / assets
- 149.6%
- Debt / equity
- —
- Book value / share
- $-8.68
- Revenue growth (YoY)
- −6.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -0.41distress
- Accruals / assets
- 31.7%high accruals
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 6 warning● 1 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- High accruals — earnings-quality risk
- Strong return on equity (>15%)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 18, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 13, 2023
- NT 10-K/Amissed a reporting deadline ↗Mar 16, 2023
- NT 10-Kmissed a reporting deadline ↗Feb 28, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 17, 2021
- NT 10-Kmissed a reporting deadline ↗Mar 16, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Pura Vida Investments, LlcActivist (13D)Mar 7, 2025
- Rtw Investments, LpPassive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeMar 10, 2025
- Delisting / listing-standard noticeMar 7, 2025
- Entered a material agreement · Bankruptcy or receivership · New financial obligation · Debt acceleration / triggering event · Regulation FD disclosure · Other material eventMar 5, 2025
- Director / officer changeFeb 18, 2025
- Director / officer changeDec 2, 2024
- Delisting / listing-standard noticeNov 22, 2024
- Results of operationsNov 7, 2024
- Delisting / listing-standard notice · Director / officer changeOct 1, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.